Home ›
Trademark Categories ›
Pharmaceuticals ›
2007 ›
EX ›
EXCEDRIN EXPRESS GELS
Trademark search for:
EXCEDRIN EXPRESS GELS
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2007-10-03 — Application filed
2007-10-09 — Application filed
2007-12-08 — Assigned to examiner
2007-12-20 — Examiners amendment and/or priority action - completed
2007-12-20 — Notification of examiner's amendment/priority action e-mailed
2007-12-20 — Examiner's amendment/priority action e-mailed
2007-12-20 — Assigned to lie
2007-12-21 — Combined examiner's amendment/priority action entered
2008-01-21 — Teas change of correspondence received
2008-01-22 — Teas/email correspondence entered
2008-01-22 — Office action issued
2008-01-22 — Correspondence received in law office
2008-03-04 — Suspension letter written
2008-03-04 — Letter of suspension e-mailed
2008-03-04 — Notification of letter of suspension e-mailed
2008-09-04 — Suspension checked - to attorney for action
2008-09-10 — Report completed suspension check case still suspended
2008-09-10 — Report completed suspension check case still suspended
2009-03-10 — Report completed suspension check case still suspended
2009-03-10 — Suspension checked - to attorney for action
2009-09-10 — Report completed suspension check case still suspended
2009-09-10 — Report completed suspension check case still suspended
2009-09-10 — Assigned to lie
2010-03-10 — Report completed suspension check case still suspended
2010-09-10 — Approved for pub - principal register
2010-09-13 — Law office publication review completed
2010-10-19 — Published for opposition
2010-10-19 — Official gazette publication confirmation e-mailed
2010-12-14 — Noa e-mailed - sou required from applicant
2011-06-13 — Teas statement of use received
2011-06-13 — Use amendment filed
2011-06-17 — Case assigned to intent to use paralegal
2011-06-17 — Statement of use processing complete
2011-07-01 — Allowed principal register - sou accepted
2011-07-02 — Law office registration review completed
2011-07-05 — Notice of acceptance of statement of use e-mailed
2011-08-09 — Registered-principal register
2015-12-02 — Attorney/dom.rep.revoked and/or appointed
2015-12-02 — Teas revoke/app/change addr of atty/dom rep received
2016-08-09 — Courtesy reminder - sec. 8 (6-yr) e-mailed
2017-05-10 — Automatic update of assignment of ownership
2018-03-16 — Cancelled sec. 8 (6-yr)
2018-03-16 — Final status recorded
Owner Information
NOVARTIS CONSUMER HEALTH S.A.
1197 PRANGINS CH
Novartis AG
Basel CH
Novartis AG
Basel CH
Novartis AG
Basel CH
Correspondent
Charles M. Atkinson GlaxoSmithKline 5 Crescent Drive LGTM - NY0300 Philadelphia, PA 19112
Filing Details
Filing Date:
2007-10-03
Status Date:
2018-03-16
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.